About DNA Script
DNA Script is a company based in Paris (France) founded in 2014 by Xavier Godron.. DNA Script has raised $301.69 million across 10 funding rounds from investors including Fidelity Investments, ARE and Agilent. DNA Script offers products and services including ssDNA Oligonucleotides, SYNTAX Platform, and SYNTAX System. DNA Script operates in a competitive market with competitors including Ansa Biotechnologies, Nuclera Nucleics, Twist Bioscience, Mesa Biotech and Nutcracker Therapeutics, among others.
- Headquarter Paris, France
- Founders Xavier Godron
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dna Script
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$301.69 M (USD)
in 10 rounds
-
Latest Funding Round
$4.32 M (USD), Grant
Sep 01, 2023
-
Investors
Fidelity Investments
& 26 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DNA Script
DNA Script offers a comprehensive portfolio of products and services, including ssDNA Oligonucleotides, SYNTAX Platform, and SYNTAX System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Synthetic DNA strands for research in mRNA and genomics.
System for rapid, on-demand custom DNA oligo production.
Device enabling in-house DNA synthesis for various applications.
Funding Insights of DNA Script
DNA Script has successfully raised a total of $301.69M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $4.32 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Grant — $4.3M
-
First Round
First Round
(12 Sep 2017)
- Investors Count 27
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - DNA Script | Valuation |
investors |
|
| Jan, 2022 | Amount | Series C - DNA Script | Valuation | eureKARE , T. Rowe Price |
|
| Oct, 2021 | Amount | Series C - DNA Script | Valuation | Coatue , Catalio Capital Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DNA Script
DNA Script has secured backing from 27 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, ARE and Agilent. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are invested in by sector-agnostic VC fund.
|
Founded Year | Domain | Location | |
|
Provider of an investment platform for various stages
|
Founded Year | Domain | Location | |
|
Venture capital is provided to biomedical technology startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DNA Script
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DNA Script
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dna Script Comparisons
Competitors of DNA Script
DNA Script operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ansa Biotechnologies, Nuclera Nucleics, Twist Bioscience, Mesa Biotech and Nutcracker Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA synthesis technology using enzymes is provided.
|
|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostic kits are developed and supplied.
|
|
| domain | founded_year | HQ Location |
mRNA therapeutics are developed via proprietary biochip platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dna Script
Frequently Asked Questions about DNA Script
When was DNA Script founded?
DNA Script was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is DNA Script located?
DNA Script is headquartered in Paris, France.
Is DNA Script a funded company?
DNA Script is a funded company, having raised a total of $301.69M across 10 funding rounds to date. The company's 1st funding round was a Series C of $165M, raised on Sep 12, 2017.
What does DNA Script do?
Founded in 2014 in Paris, France, DNA Script operates in the biotechnology sector. A benchtop DNA printer powered by enzymatic technology is developed for nucleic acid synthesis. Outsourced DNA synthesis services are provided, replacing traditional chemical methods with enzymatic approaches. The companys operations focus on enabling on-demand DNA production in laboratory settings across Europe and beyond.
Who are the top competitors of DNA Script?
DNA Script's top competitors include Nuclera Nucleics, Twist Bioscience and Ansa Biotechnologies.
What products or services does DNA Script offer?
DNA Script offers ssDNA Oligonucleotides, SYNTAX Platform, and SYNTAX System.
Who are DNA Script's investors?
DNA Script has 27 investors. Key investors include Fidelity Investments, ARE, Agilent, Merck, and T. Rowe Price.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.